GMP obtains two patents involving bag proteins and nucleic acid molecules encoding them and porous biodegradable polymeric materials for cell transplantation.GMP GMP (guanosine monophosphate): see guanine. Companies, Inc. (Fort Lauderdale, FL), a company that acquires, develops and commercializes pharmaceutical, diagnostic and medical device technologies, announced that the United States Patent and Trademark Office The United States Patent and Trademark Office (PTO or USPTO) is an agency in the United States Department of Commerce that provides patent protection to inventors and businesses for their inventions, and trademark registration for product and intellectual property has issued two patents on proprietary technologies exclusively licensed to the company. One issued patent is on proprietary cancer biomarkers under development for the early detection and prognosis of breast cancer. The second patent is for proprietary tissue engineering technology under development for spinal cord spinal cord, the part of the nervous system occupying the hollow interior (vertebral canal) of the series of vertebrae that form the spinal column, technically known as the vertebral column. repair, restoration of spinal cord function and potentially other neurological disorders, using natural and synthetic materials. The cancer biomarkers patent is issued to The Burnham Institute (La Jolla, CA), and the tissue engineering patent is issued to the Massachusetts Institute of Technology Massachusetts Institute of Technology, at Cambridge; coeducational; chartered 1861, opened 1865 in Boston, moved 1916. It has long been recognized as an outstanding technological institute and its Sloan School of Management has notable programs in business, and Children's Hospital Boston Children's Hospital Boston is a children's hospital located in the Longwood Medical and Academic Area of Boston, Massachusetts. Located at 300 Longwood Avenue, Children's is adjacent both to its teaching affiliate, Harvard Medical School, and to Dana-Farber Cancer Institute. . The cancer biomarkers patent , United States Patent 6,696,558 will remain in force until 2019. The tissue engineering patent, United States Patent 6,689,608, will remain in force until 2013. The cancer biomarkers patent covers a family of BAG-1 related genes from humans (additional claims are pending). The tissue engineering patent covers biodegradable, biocompatible biocompatible /bio·com·pat·i·ble/ (-kom-pat´i-b'l) being harmonious with life; not having toxic or injurious effects on biological function. polymeric materials used to make pliable, non-toxic, injectible porous templates for neural cell growth. GMP and its subsidiaries acquire, develop and commercialize pharmaceutical, diagnostic and medical device technologies. These technologies are typically licensed or acquired from academic medical centers, individual inventors, research institutions and partner companies. GMP Companies is developing and commercializing various medical technologies relating to the treatment and care of patients with medical conditions associated with diabetes, glaucoma glaucoma (glôkō`mə), ocular disorder characterized by pressure within the eyeball caused by an excessive amount of aqueous humor (the fluid substance filling the eyeball). , cardiovascular diseases, immunologic diseases, cancer, neurological disorders and infection control. GMP Companies, Inc. +1-954-745-3537 www.gmpcompanies.com The Burnham Institute, +1-858-646-3146 www.burnham.org |
|
||||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion